Kairos Pharma Ltd.

AMEX: KAPA · Real-Time Price · USD
1.06
-0.04 (-3.64%)
At close: Aug 20, 2025, 3:59 PM
1.11
4.72%
Pre-market: Aug 21, 2025, 05:35 AM EDT

Kairos Pharma Statistics

Share Statistics

Kairos Pharma has 20.74M shares outstanding. The number of shares has increased by 31.21% in one year.

20.74M
31.21%
22.98%
n/a
8.77M
5,690
0.11%

Short Selling Information

The latest short interest is 869.28K, so 5.16% of the outstanding shares have been sold short.

869.28K
5.16%
8.61%
1

Valuation Ratios

The PE ratio is -6.63 and the forward PE ratio is -2.96. Kairos Pharma's PEG ratio is -0.19.

-6.63
-2.96
0
n/a
3.61
-4.36
-0.19
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Kairos Pharma.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 4.2, with a Debt / Equity ratio of 0.

4.2
4.2
0
n/a
n/a
-2.73

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-2.6M
1
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 2.06, so Kairos Pharma's price volatility has been higher than the market average.

2.06
n/a
0.84
1.11
55.75
5,293,453

Income Statement

n/a
-160K
-2.34M
-2.6M
-2.34M
-2.64M
-0.23
Full Income Statement

Balance Sheet

The company has 1.27M in cash and 0 in debt, giving a net cash position of 1.27M.

1.27M
n/a
n/a
-8.81M
6.67M
4.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.96M and capital expenditures 0, giving a free cash flow of -3.96M.

-3.96M
n/a
-3.96M
-0.35
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

KAPA does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for KAPA is $9, which is 749.1% higher than the current price. The consensus rating is "Buy".

$9
749.1%
Buy
3
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

17.64
2